Search research articles
Contact Us
Filters
Showing results (1-10 of 122) with videos related to
Page
of 13
Sort By:
Malaria Journal
|
October 21, 2003
Zooprophylaxis or zoopotentiation: the outcome of introducing animals on vector transmission is highly dependent on the mosquito mortality while searching
Allan Saul
Vaccine
|
April 7, 2005
Models of Phase 1 vaccine trials: optimization of trial design to minimize risks of multiple serious adverse events
Allan Saul
The Journal of Infectious Diseases
|
December 28, 2006
Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
Allan Saul
Nature Medicine
|
May 4, 2004
The mosquito's innate sting
Allan Saul
Current Opinion in Infectious Diseases
|
September 1, 2007
Mosquito stage, transmission blocking vaccines for malaria
Allan Saul
Journal of Infection in Developing Countries
|
September 10, 2009
The Novartis Vaccines Institute for Global Health: a new initiative for developing vaccines for neglected diseases in developing countries
Allan Saul, Rino Rappuoli
Nature
|
February 8, 2002
Progress and challenges for malaria vaccines
Thomas L Richie, Allan Saul
Methods in Molecular Biology (Clifton, N.J.)
|
August 6, 2005
Extraction and characterization of vaccine antigens from water-in-oil adjuvant formulations
Aaron P Miles, Allan Saul
Vaccine
|
December 27, 2016
Prioritizing vaccines for developing world diseases
Allan Saul, Katherine L O'Brien
Methods in Molecular Biology (Clifton, N.J.)
|
August 6, 2005
Quantifying recombinant proteins and their degradation products using SDS-PAGE and scanning laser densitometry
Aaron P Miles, Allan Saul
Page
of 13
Search research articles
Search
Showing results (1-10 of 122) with videos related to
Sort By:
Page
of 13
Malaria Journal
|
October 21, 2003
Zooprophylaxis or zoopotentiation: the outcome of introducing animals on vector transmission is highly dependent on the mosquito mortality while searching
Allan Saul
Vaccine
|
April 7, 2005
Models of Phase 1 vaccine trials: optimization of trial design to minimize risks of multiple serious adverse events
Allan Saul
The Journal of Infectious Diseases
|
December 28, 2006
Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
Allan Saul
Nature Medicine
|
May 4, 2004
The mosquito's innate sting
Allan Saul
Current Opinion in Infectious Diseases
|
September 1, 2007
Mosquito stage, transmission blocking vaccines for malaria
Allan Saul
Journal of Infection in Developing Countries
|
September 10, 2009
The Novartis Vaccines Institute for Global Health: a new initiative for developing vaccines for neglected diseases in developing countries
Allan Saul, Rino Rappuoli
Nature
|
February 8, 2002
Progress and challenges for malaria vaccines
Thomas L Richie, Allan Saul
Methods in Molecular Biology (Clifton, N.J.)
|
August 6, 2005
Extraction and characterization of vaccine antigens from water-in-oil adjuvant formulations
Aaron P Miles, Allan Saul
Vaccine
|
December 27, 2016
Prioritizing vaccines for developing world diseases
Allan Saul, Katherine L O'Brien
Methods in Molecular Biology (Clifton, N.J.)
|
August 6, 2005
Quantifying recombinant proteins and their degradation products using SDS-PAGE and scanning laser densitometry
Aaron P Miles, Allan Saul
Page
of 13